Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Awareness of the implementation of the falsified medicines directive (fmd) among pharmaceutical companies’ executives in the european economic area (eea)

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: MERKS, Piotr (Collegium Medicum, Nicolaus Copernicus University in Toruń, Department of Pharmaceutical Technology, Faculty of Pharmacy, Bydgoszcz, Poland)
  • Co-author(s): Urszula Włodarczak Department of Pharmaceutical Technology, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland
    Damian Świeczkowski First Department of Cardiology, Medical University of Gdansk, Poland , Gdansk, Poland
    Urszula Religioni Collegium of Socio-Economics, Warsaw School of Economics, Warsaw, Poland
    Milosz Jaguszewski First Department of Cardiology, Medical University of Gdansk, Poland, Gdansk, Poland
    Jerzy Krysinski Department of Pharmaceutical Technology, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland
    Piotr Merks
  • Abstract:

    Background

    FMD is a response of the European Union to the increasing number of falsified medicines present in the legal supply chain in the Member States of the Community. Effective implementation of the new regulation will depend on, among others, effective cooperation of all parties involved in the distribution of medicinal products including the

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses